China Zenix Auto International Ltd (NYSE:ZX) announced its unaudited financial results for the fourth quarter and year ended December 31, 2013.Revenue was RMB982.7 million (US$162.3 million) compared with RMB800.1 million;Profit and total comprehensive income for the period rose 15.7% to RMB54.4 million (US$9.0 million) with earnings per American Depositary Share (“ADS”) of RMB1.05 (US$0.17).China Zenix Auto International Ltd (NYSE:ZX) shares moved down-5.81% in last trading session and was closed at $2.43, while trading in range of $2.37 – $2.65. China Zenix Auto International Ltd (NYSE:ZX) year to date (YTD) performance is -6.54%.
United States Antimony Corporation (NYSEMKT:UAMY)shares after opening at $1.92 on last trade day and at the end of the day closed at $1.86. Company price to sales ratio in past twelve months was calculated as 10.70 and price to cash ratio as 588.50. United States Antimony Corporation (NYSEMKT:UAMY) showed a negative weekly performance of -8.37%.
Adcare Health System (NYSE:ADK) Director Laurence Sturtz sold 4,100 shares of Adcare Health System stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $4.11, for a total value of $16,851.00. Following the completion of the transaction, the director now directly owns 90,088 shares of the company’s stock, valued at approximately $370,262.AdCare Health Systems, Inc. (NYSEMKT:ADK) shares fell-5.78% in last trading session and ended the day on $3.75. ADK return on equity ratio is recorded as -117.20% and its return on assets is -5.80%. AdCare Health Systems, Inc. (NYSEMKT:ADK) yearly performance is -36.22%.
Verso Paper Corp. (NYSE:VRS) mill was a key part of Sartell before it was put out of commission by a 2012 fire. Now, a local artist and Sartell High School teacher have found a way to keep pieces of the mill in the community.Verso Paper Corp. (NYSE:VRS) weekly performance is -9.23%. On last trading day company shares ended up $2.46.Verso Paper Corp. (NYSE:VRS) distance from 50-day simple moving average (SMA50) is -5.24%. Analysts mean target price for the company is $1.50.